The Australian stock market is experiencing a slight downturn, with the ASX 200 poised for a modest drop as tech sector challenges in the U.S. ripple across global markets. Amidst this cautious atmosphere, investors may find opportunities in stocks that are trading below their fair value, particularly those resilient to inflation and interest rate pressures.
Top 10 Undervalued Stocks Based On Cash Flows In Australia
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Xero (ASX:XRO) | A$69.72 | A$135.35 | 48.5% |
| Superloop (ASX:SLC) | A$3.12 | A$5.59 | 44.2% |
| PolyNovo (ASX:PNV) | A$0.98 | A$1.89 | 48% |
| Navigator Global Investments (ASX:NGI) | A$2.36 | A$4.67 | 49.4% |
| Magellan Financial Group (ASX:MFG) | A$9.70 | A$17.12 | 43.3% |
| Kogan.com (ASX:KGN) | A$4.19 | A$7.42 | 43.5% |
| Frontier Digital Ventures (ASX:FDV) | A$0.345 | A$0.62 | 44.5% |
| Electro Optic Systems Holdings (ASX:EOS) | A$7.03 | A$13.58 | 48.2% |
| Betr Entertainment (ASX:BBT) | A$0.175 | A$0.34 | 48.4% |
| Aroa Biosurgery (ASX:ARX) | A$0.585 | A$1.04 | 43.6% |
Let's review some notable picks from our screened stocks.
ALS (ASX:ALQ)
Overview: ALS Limited provides professional technical and analytical services focused on testing, measurement, and inspection across regions including Africa, Asia Pacific, Europe, the Middle East, North Africa, and the United States with a market cap of A$11.15 billion.
Operations: The company's revenue is primarily derived from its Commodities segment, generating A$1.29 billion, and its Life Sciences segment, contributing A$2.03 billion.
Estimated Discount To Fair Value: 20.7%
ALS Limited is trading at A$21.96, below its estimated future cash flow value of A$27.69, suggesting it is undervalued by over 20%. Despite a high debt level, ALS has shown strong earnings growth of 24.4% in the past year and is forecast to grow earnings at 12.6% annually, outpacing the Australian market's growth rate. Recent inclusion in major indices like S&P/ASX 50 reflects confidence in its strategic direction and financial health.
- Our earnings growth report unveils the potential for significant increases in ALS' future results.
- Click to explore a detailed breakdown of our findings in ALS' balance sheet health report.
Lynas Rare Earths (ASX:LYC)
Overview: Lynas Rare Earths Limited is involved in the exploration, development, mining, extraction, and processing of rare earth minerals in Australia and Malaysia with a market cap of A$15.99 billion.
Operations: The company's revenue primarily comes from its Rare Earth Operations, which generated A$715.89 million.
Estimated Discount To Fair Value: 25.3%
Lynas Rare Earths, trading at A$15.89, is undervalued relative to its estimated future cash flow value of A$21.28, with a discount exceeding 20%. The company anticipates robust revenue growth of 25.6% annually, surpassing the Australian market's average. Earnings are projected to increase significantly at 43% per year, well above market expectations. However, a forecasted return on equity of 19.5% in three years may temper some investor enthusiasm despite strong growth prospects.
- The growth report we've compiled suggests that Lynas Rare Earths' future prospects could be on the up.
- Take a closer look at Lynas Rare Earths' balance sheet health here in our report.
Temple & Webster Group (ASX:TPW)
Overview: Temple & Webster Group Ltd operates as an online retailer specializing in furniture, homewares, and home improvement products in Australia, with a market capitalization of A$601.38 million.
Operations: The company generates revenue of A$662.87 million from the online sale of furniture, homewares, and home improvement products in Australia.
Estimated Discount To Fair Value: 28.7%
Temple & Webster Group is trading at A$5.16, significantly below its estimated future cash flow value of A$7.24, offering a discount of over 20%. Earnings are projected to grow substantially at 31% annually, outpacing the Australian market's average growth. Despite being dropped from major indices in June 2026 and a forecasted low return on equity of 14% in three years, recent share buybacks totaling A$29.84 million suggest confidence in its valuation potential.
- According our earnings growth report, there's an indication that Temple & Webster Group might be ready to expand.
- Click here and access our complete balance sheet health report to understand the dynamics of Temple & Webster Group.
Seize The Opportunity
- Click this link to deep-dive into the 37 companies within our Undervalued ASX Stocks Based On Cash Flows screener.
- Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
- Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.
Curious About Other Options?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com